Literature DB >> 28921181

7-Nitroindazole, a selective inhibitor of neuronal nitric oxide synthase: effect on sevoflurane MAC and cerebellar cyclic GMP in mice.

Wei-Dong Mi1, Fumito Ichinose1, Takahisa Goto1, Yoshinari Niimi1, Masanori Uchiyama2, Shigeho Morita1.   

Abstract

PURPOSE: Considerable evidence suggests that nitric oxide (NO) plays a role in synaptic transmission in the central and peripheral nervous systems. However, whether inhibition of NO synthesis decreases minimum alveolar concentration (MAC) of inhalational anesthetics is controversial. We examined the effects of 7-nitroindazole (7-NI), a selective inhibitor of neuronal NOS (nNOS), on the MAC of sevoflurane and cerebellar cyclic guanosine monophosphate (cGMP) levels in mice.
METHODS: Sevoflurane MAC and cerebellar cGMP levels were determined in mice after acute intraperitoneal or weeklong gavage feeding of 7-NI. Sevoflurane MAC and cerebellar cGMP levels after chronic treatment were measured on days 1, 4, and 7 and were repeated after an acute intraperitoneal dose of nitro g -L-arginine methylester (L-NAME).
RESULTS: Acute and chronic treatment with 7-NI decreased the sevoflurane MAC by 20%-30%. Reduction of cerebellar cGMP levels was greater after intraperitoneal administration of NOS inhibitors than after gavage feeding of 7-NI.
CONCLUSION: Acute or chronic selective inhibition of neuronal NOS decreases the sevoflurane MAC and cerebellar cGMP levels in mice. 7-NI permitted probing of the role of NO in perception of noxious stimuli.

Entities:  

Keywords:  MAC; Mouse; NOS inhibitor; Nitric oxide; Nitric oxide synthase; Potency; Sevoflurane; Volatile anesthetics

Year:  1998        PMID: 28921181     DOI: 10.1007/BF02480092

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  24 in total

Review 1.  Neurons that say NO.

Authors:  S R Vincent; B T Hope
Journal:  Trends Neurosci       Date:  1992-03       Impact factor: 13.837

Review 2.  Nitric oxide, a novel biologic messenger.

Authors:  C J Lowenstein; S H Snyder
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

Review 3.  Nitric oxide synthase structure and mechanism.

Authors:  M A Marletta
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

4.  Potencies of inhaled anesthetics and alcohol in mice selectively bred for resistance and susceptibility to nitrous oxide anesthesia.

Authors:  D D Koblin; J E Deady; E I Eger
Journal:  Anesthesiology       Date:  1982-01       Impact factor: 7.892

5.  L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse.

Authors:  P K Moore; A O Oluyomi; R C Babbedge; P Wallace; S L Hart
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

6.  Effects of targeted neuronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia.

Authors:  F Ichinose; P L Huang; W M Zapol
Journal:  Anesthesiology       Date:  1995-07       Impact factor: 7.892

7.  Anesthetic potencies and the unitary theory of narcosis.

Authors:  J E Deady; D D Koblin; E I Eger; J E Heavner; B D'Aoust
Journal:  Anesth Analg       Date:  1981-06       Impact factor: 5.108

8.  Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness?

Authors:  R A Johns; J C Moscicki; C A DiFazio
Journal:  Anesthesiology       Date:  1992-10       Impact factor: 7.892

9.  Spinal cholinergic alpha-2 adrenergic interactions in analgesia and hemodynamic control: role of muscarinic receptor subtypes and nitric oxide.

Authors:  A Lothe; P Li; C Tong; Y Yoon; H Bouaziz; D J Detweiler; J C Eisenach
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

10.  Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration.

Authors:  T Adachi; T Shinomura; S Nakao; J Kurata; M Murakawa; T Shichino; N Seo; K Mori
Journal:  Anesth Analg       Date:  1995-10       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.